Pharmaceutical News

RSS

1 in 10 prescription drugs has industry-sponsored patient support program

About 1 in 10 prescription drugs -; mainly brand-name and expensive drugs and those for rare diseases -; has a manufacturer-sponsored patient support program, which usually includes financial, nursing and educational supports.

27 Nov 2023

Half-dose COVID-19 booster elicits similar immune response with fewer side effects

Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study.

23 Nov 2023

Curbing pharmaceutical effluent pollution: A crucial step in fighting antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat, especially in low- and middle-income countries (LMICs), causing prolonged illnesses, heightened antimicrobial use, increased healthcare expenses, and avoidable deaths.

23 Nov 2023

Sickle Cell Disease patients and the use of disease-modifying treatments

New disease-modifying treatments (DMTs), namely, crizanlizumab, L-glutamine, and voxelotor, have recently been approved.

23 Nov 2023

Numbing agent lidocaine may have cancer-fighting properties

Lidocaine-;often used as numbing agent for outpatient medical procedures-;activates certain bitter taste receptors through two unique mechanisms that result in cancer cell death, according to researchers from the Perelman School of Medicine at the University of Pennsylvania.

22 Nov 2023

Repurposed drugs hold promise for targeting cancer stem cells

In a review published in the journal Genes & Diseases, researchers from ICMR-National Institute of Nutrition (NIN), advocate for the repurposing of non-cancer drugs to target these elusive CSCs.

22 Nov 2023

Anti-rheumatic drugs could have a preventive effect on autoimmune thyroid disease

Anti-rheumatic drugs used for rheumatoid arthritis might prevent the development of autoimmune thyroid disease, according to a new observational study by researchers from Karolinska Institutet published in the Journal of Internal Medicine.

22 Nov 2023

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.

22 Nov 2023

Call for improved data sharing practices in the pharmaceutical industry

Development of potential or improved anti-cancer treatments are being blocked or slowed down by lack of transparency in data sharing between pharmaceutical companies and research groups, according to cancer clinicians, researchers and consumers.

21 Nov 2023

Evolving overdose crisis shakes previously effective treatments

"You can't inject a horse tranquilizer and think nothing bad is gonna happen" to you, said Ty Sears, 33, a longtime drug user now in recovery.

21 Nov 2023

Study highlights rise in pain medication dependence due to medical negligence

Dependence on pain medication is on the rise due to lack of vigilance by medical professionals, according to a new study from the University of Surrey.

20 Nov 2023

Novel antidepressant zuranolone effective in alleviating depression and anxiety symptoms

The efficacy and safety of zuranolone in treating major depressive disorder (MDD).

20 Nov 2023

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.

20 Nov 2023

Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

The TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline.

20 Nov 2023

Norwegian study looks at which medicines best prevent migraine

Migraine is more than just a headache. Often the pain is accompanied by nausea, vomiting, light sensitivity, and sound sensitivity.

17 Nov 2023

RIT scientist earns NIH award to support research on building the next generation of drugs

Rochester Institute of Technology's Emiliano Brini, assistant professor in the School of Chemistry and Materials Science, has received an award from the National Institutes of Health (NIH) to support his research on building the next generation of drugs.

17 Nov 2023

Unraveling the immune system's response to nanoparticle drug delivery

To reduce the side effects associated with chemotherapy treatments, researchers have investigated the use of delivery systems that can take more drugs directly to the tumor. Ninh (Irene) La-Beck, Pharm.D., from the Department of Immunotherapeutics and Biotechnology at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy is one of those researchers.

17 Nov 2023

Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world's most devastating infectious diseases: tuberculosis (TB).

16 Nov 2023

Study highlights variable use and rising costs of antivirals in treating pediatric influenza in the U.S.

The Pediatrics study analyzes trends in antiviral usage among U.S. children and adolescents with influenza, revealing significant variations in dispensing rates and costs, and low usage among children under six years, emphasizing the need for improved treatment strategies.

16 Nov 2023

Insulin manufacturers extend market exclusivity through additional patents, study finds

Over the last four decades, insulin manufacturers have extended their periods of market exclusivity on brand-name insulin products by employing several strategies, including filing additional patents on their products after FDA approval and obtaining many patents on delivery devices for their insulin products.

16 Nov 2023

Previous
1
...
31
32
33
34
35
36
37
...
1433
Next

Pharmaceutical News

1 in 10 prescription drugs has industry-sponsored patient support program

Half-dose COVID-19 booster elicits similar immune response with fewer side effects

Curbing pharmaceutical effluent pollution: A crucial step in fighting antimicrobial resistance

Sickle Cell Disease patients and the use of disease-modifying treatments

Numbing agent lidocaine may have cancer-fighting properties

Repurposed drugs hold promise for targeting cancer stem cells

Anti-rheumatic drugs could have a preventive effect on autoimmune thyroid disease

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Call for improved data sharing practices in the pharmaceutical industry

Evolving overdose crisis shakes previously effective treatments

Study highlights rise in pain medication dependence due to medical negligence

Novel antidepressant zuranolone effective in alleviating depression and anxiety symptoms

MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

Norwegian study looks at which medicines best prevent migraine

RIT scientist earns NIH award to support research on building the next generation of drugs

Unraveling the immune system's response to nanoparticle drug delivery

Promising new cancer therapy appears to be extremely potent against tuberculosis

Study highlights variable use and rising costs of antivirals in treating pediatric influenza in the U.S.

Insulin manufacturers extend market exclusivity through additional patents, study finds

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News